158 related articles for article (PubMed ID: 36207763)
1. Bridging therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis on intention-to-treat outcomes.
Di Martino M; Ferraro D; Pisaniello D; Arenga G; Falaschi F; Terrone A; Maniscalco M; Galeota Lanza A; Esposito C; Vennarecci G
J Hepatobiliary Pancreat Sci; 2023 Apr; 30(4):429-438. PubMed ID: 36207763
[TBL] [Abstract][Full Text] [Related]
2. Downstaging Therapies for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation: A Systematic Review and Meta-Analysis on Intention-to-Treat Outcomes.
Di Martino M; Vitale A; Ferraro D; Maniscalco M; Pisaniello D; Arenga G; Falaschi F; Terrone A; Iacomino A; Galeota Lanza A; Esposito C; Cillo U; Vennarecci G
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291885
[TBL] [Abstract][Full Text] [Related]
3. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.
Kulik L; Heimbach JK; Zaiem F; Almasri J; Prokop LJ; Wang Z; Murad MH; Mohammed K
Hepatology; 2018 Jan; 67(1):381-400. PubMed ID: 28859222
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit of transplantation for recurrence of hepatocellular carcinoma after liver resection.
Tuci F; Vitale A; D'Amico F; Gringeri E; Neri D; Zanus G; Bassi D; Polacco M; Boetto R; Lodo E; Germani G; Burra P; Angeli P; Cillo U
Transplant Proc; 2014 Sep; 46(7):2287-9. PubMed ID: 25242770
[TBL] [Abstract][Full Text] [Related]
5. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.
Pompili M; Francica G; Ponziani FR; Iezzi R; Avolio AW
World J Gastroenterol; 2013 Nov; 19(43):7515-30. PubMed ID: 24282343
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
Lee MW; Raman SS; Asvadi NH; Siripongsakun S; Hicks RM; Chen J; Worakitsitisatorn A; McWilliams J; Tong MJ; Finn RS; Agopian VG; Busuttil RW; Lu DSK
Hepatology; 2017 Jun; 65(6):1979-1990. PubMed ID: 28170115
[TBL] [Abstract][Full Text] [Related]
8. Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation.
Goldaracena N; Gorgen A; Doyle A; Hansen BE; Tomiyama K; Zhang W; Ghanekar A; Lilly L; Cattral M; Galvin Z; Selzner M; Bhat M; Selzner N; McGilvray I; Greig PD; Grant DR; Sapisochin G
J Hepatol; 2019 Apr; 70(4):666-673. PubMed ID: 30630009
[TBL] [Abstract][Full Text] [Related]
9. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
[TBL] [Abstract][Full Text] [Related]
10. Reframing the approach to patients with hepatocellular carcinoma: Longitudinal assessment with hazard associated with liver transplantation for HCC (HALTHCC) improves ablate and wait strategy.
Firl DJ; Kimura S; McVey J; Hashimoto K; Yeh H; Miller CM; Markmann JF; Sasaki K; Aucejo FN
Hepatology; 2018 Oct; 68(4):1448-1458. PubMed ID: 29604231
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.
Menahem B; Lubrano J; Duvoux C; Mulliri A; Alves A; Costentin C; Mallat A; Launoy G; Laurent A
Liver Transpl; 2017 Jun; 23(6):836-844. PubMed ID: 28295992
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma: interventional bridging to liver transplantation.
Lubienski A
Transplantation; 2005 Sep; 80(1 Suppl):S113-9. PubMed ID: 16286887
[TBL] [Abstract][Full Text] [Related]
13. Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma.
Aravinthan AD; Bruni SG; Doyle AC; Thein HH; Goldaracena N; Issachar A; Lilly LB; Selzner N; Bhat M; Sreeharsha B; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Greig PD; Renner EL; Grant DR; Sapisochin G
Ann Surg Oncol; 2017 Jul; 24(7):1843-1851. PubMed ID: 28160137
[TBL] [Abstract][Full Text] [Related]
14. Bridging to liver transplantation in HCC patients.
Kollmann D; Selzner N; Selzner M
Langenbecks Arch Surg; 2017 Sep; 402(6):863-871. PubMed ID: 28755240
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for hepatocellular carcinoma in New Zealand: a prospective intent-to-treat analysis.
Marui Y; McCall J; Gane E; Holden A; Duncan D; Yeong ML; Chow K; Munn S
N Z Med J; 2005 Jun; 118(1217):U1532. PubMed ID: 15980906
[TBL] [Abstract][Full Text] [Related]
16. Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer.
Lai Q; Vitale A; Iesari S; Finkenstedt A; Mennini G; Spoletini G; Hoppe-Lotichius M; Vennarecci G; Manzia TM; Nicolini D; Avolio AW; Frigo AC; Graziadei I; Rossi M; Tsochatzis E; Otto G; Ettorre GM; Tisone G; Vivarelli M; Agnes S; Cillo U; Lerut J;
Hepatology; 2017 Dec; 66(6):1910-1919. PubMed ID: 28653750
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Intention-to-Treat Benefit of Living Donation in Patients With Hepatocellular Carcinoma Awaiting a Liver Transplant.
Lai Q; Sapisochin G; Gorgen A; Vitale A; Halazun KJ; Iesari S; Schaefer B; Bhangui P; Mennini G; Wong TCL; Uemoto S; Lin CC; Mittler J; Ikegami T; Yang Z; Frigo AC; Zheng SS; Soejima Y; Hoppe-Lotichius M; Chen CL; Kaido T; Lo CM; Rossi M; Soin AS; Finkenstedt A; Emond JC; Cillo U; Lerut JP
JAMA Surg; 2021 Sep; 156(9):e213112. PubMed ID: 34259797
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.
Wong TCL; Ng KKC; Fung JYY; Chan AAC; Cheung TT; Chok KSH; Dai JWC; Lo CM
Ann Surg Oncol; 2019 May; 26(5):1454-1462. PubMed ID: 30737669
[TBL] [Abstract][Full Text] [Related]
19. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria.
Degroote H; Piñero F; Costentin C; Notarpaolo A; Boin IF; Boudjema K; Baccaro C; Chagas AL; Bachellier P; Ettorre GM; Poniachik J; Muscari F; Di Benedetto F; Duque SH; Salame E; Cillo U; Gadano A; Vanlemmens C; Fagiuoli S; Rubinstein F; Burra P; Cherqui D; Silva M; Van Vlierberghe H; Duvoux C;
JHEP Rep; 2021 Oct; 3(5):100331. PubMed ID: 34485882
[TBL] [Abstract][Full Text] [Related]
20. Resection vs Transplant Listing for Hepatocellular Carcinoma: An Intention-to-Treat Analysis.
Meyerovich G; Goykhman Y; Nakache R; Nachmany I; Lahat G; Shibolet O; Menachem Y; Katchman H; Wolf I; Geva R; Klausner JM; Lubezky N
Transplant Proc; 2019; 51(6):1867-1873. PubMed ID: 31399171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
